Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging

Purpose. The increased use of magnetic resonance imaging (MRI) has resulted in reports of incidental abnormal bone marrow (BM) signal. Our goal was to determine the evaluation of an incidental abnormal BM signal on MRI and the prevalence of a subsequent oncologic diagnosis. Methods. We conducted a r...

Full description

Saved in:
Bibliographic Details
Main Authors: Gunjan L. Shah, Aaron S. Rosenberg, Jamie Jarboe, Andreas Klein, Furha Cossor
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/380814
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558009121767424
author Gunjan L. Shah
Aaron S. Rosenberg
Jamie Jarboe
Andreas Klein
Furha Cossor
author_facet Gunjan L. Shah
Aaron S. Rosenberg
Jamie Jarboe
Andreas Klein
Furha Cossor
author_sort Gunjan L. Shah
collection DOAJ
description Purpose. The increased use of magnetic resonance imaging (MRI) has resulted in reports of incidental abnormal bone marrow (BM) signal. Our goal was to determine the evaluation of an incidental abnormal BM signal on MRI and the prevalence of a subsequent oncologic diagnosis. Methods. We conducted a retrospective cohort study of patients over age 18 undergoing MRI between May 2005 and October 2010 at Tufts Medical Center (TMC) with follow-up through November 2013. The electronic medical record was queried to determine imaging site, reason for scan, evaluation following radiology report, and final diagnosis. Results. 49,678 MRIs were done with 110 patients meeting inclusion criteria. Twenty two percent underwent some evaluation, most commonly a complete blood count, serum protein electrophoresis, or bone scan. With median follow-up of 41 months, 6% of patients were diagnosed with malignancies including multiple myeloma, non-Hodgkins lymphoma, metastatic non-small cell lung cancer, and metastatic adenocarcinoma. One patient who had not undergone evaluation developed breast cancer 24 months after the MRI. Conclusions. Incidentally noted abnormal or heterogeneous bone marrow signal on MRI was not inconsequential and should prompt further evaluation.
format Article
id doaj-art-02315498e51c4c44a6eead5e14e0db97
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-02315498e51c4c44a6eead5e14e0db972025-02-03T01:33:26ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/380814380814Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance ImagingGunjan L. Shah0Aaron S. Rosenberg1Jamie Jarboe2Andreas Klein3Furha Cossor4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, P.O. Box 298, New York, NY 10065, USADivision of Hematology/Oncology, UC Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA 95817, USAGraves Gilbert Clinic, 201 Park Street, Bowling Green, KY 42102, USATufts Medical Center, 800 Washington Street, P.O. Box 245, Boston, MA 02111, USALahey Hospital & Medical Center, 41 Mall Road, Burlington, MA 01805, USAPurpose. The increased use of magnetic resonance imaging (MRI) has resulted in reports of incidental abnormal bone marrow (BM) signal. Our goal was to determine the evaluation of an incidental abnormal BM signal on MRI and the prevalence of a subsequent oncologic diagnosis. Methods. We conducted a retrospective cohort study of patients over age 18 undergoing MRI between May 2005 and October 2010 at Tufts Medical Center (TMC) with follow-up through November 2013. The electronic medical record was queried to determine imaging site, reason for scan, evaluation following radiology report, and final diagnosis. Results. 49,678 MRIs were done with 110 patients meeting inclusion criteria. Twenty two percent underwent some evaluation, most commonly a complete blood count, serum protein electrophoresis, or bone scan. With median follow-up of 41 months, 6% of patients were diagnosed with malignancies including multiple myeloma, non-Hodgkins lymphoma, metastatic non-small cell lung cancer, and metastatic adenocarcinoma. One patient who had not undergone evaluation developed breast cancer 24 months after the MRI. Conclusions. Incidentally noted abnormal or heterogeneous bone marrow signal on MRI was not inconsequential and should prompt further evaluation.http://dx.doi.org/10.1155/2014/380814
spellingShingle Gunjan L. Shah
Aaron S. Rosenberg
Jamie Jarboe
Andreas Klein
Furha Cossor
Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
The Scientific World Journal
title Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
title_full Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
title_fullStr Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
title_full_unstemmed Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
title_short Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging
title_sort incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging
url http://dx.doi.org/10.1155/2014/380814
work_keys_str_mv AT gunjanlshah incidenceandevaluationofincidentalabnormalbonemarrowsignalonmagneticresonanceimaging
AT aaronsrosenberg incidenceandevaluationofincidentalabnormalbonemarrowsignalonmagneticresonanceimaging
AT jamiejarboe incidenceandevaluationofincidentalabnormalbonemarrowsignalonmagneticresonanceimaging
AT andreasklein incidenceandevaluationofincidentalabnormalbonemarrowsignalonmagneticresonanceimaging
AT furhacossor incidenceandevaluationofincidentalabnormalbonemarrowsignalonmagneticresonanceimaging